United Therapeutics
UTHR
#986
Rank
A$35.76 B
Marketcap
A$839.71
Share price
-3.16%
Change (1 day)
14.36%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2026 (TTM): A$41.73

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is A$42.97. In 2025 the company made an earnings per share (EPS) of A$45.33 an increase over its 2024 EPS that were of A$39.73.

EPS history for United Therapeutics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$41.73-7.95%
2025A$45.3314.1%
2024A$39.7325.59%
2023A$31.6331.54%
2022A$24.0551.18%
2021A$15.91-9.1%
2020A$17.50-581.4%
2019A-$3.63-117.79%
2018A$20.4342.11%
2017A$14.37-40.93%
2016A$24.3313.45%
2015A$21.45104.29%
2014A$10.50100.29%
2013A$5.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.07-97.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$46.39 7.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A-$2.12-104.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$4.66-110.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
A$11.65-72.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.32-89.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
A-$9.07-121.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$0.68-98.43%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel